A strategic adjuvant therapy of osteosarcoma

Area of Science:

• Oncology
• Medical Research

Background:

• Osteogenic sarcoma of the limbs presents a significant treatment challenge.
• Multimodal treatment strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy and toxicity of an early combination treatment for limb osteogenic sarcoma.
• To assess the impact of whole lung irradiation and intensive chemotherapy on disease recurrence.

Main Methods:

• Twenty-one patients received 1,750 rad whole lung irradiation and cyclic chemotherapy (methotrexate, vincristine, mitomycin C, adriamycin, DTIC, cyclophosphamide) with immuno-BCG.
• Primary lesions were managed via amputation or 8,000 rad irradiation.
• Patient follow-up ranged from 6 to 29 months.

Main Results:

• Eighteen out of 21 patients remained disease-free.
• Three patients relapsed after delays in treatment completion (8, 11, and 22 months).
• No local relapses were observed, and the protocol's toxicity was deemed acceptable.

Conclusions:

• The combined treatment shows promising efficacy in preventing recurrence for limb osteogenic sarcoma.
• Treatment delays may be associated with relapse.
• Further investigation is required to fully understand lung tolerance and long-term efficacy.